Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Columbia researchers are working to determine the prevalence of autoimmune diabetes with a monogenic cause and the factors that can identify those most likely to have it.
Pediatric researchers at Columbia are joining colleagues at 25 institutions across the country to understand more about long COVID and mitigate future impact.
Christopher J. Petit, MD, internationally recognized for clinical innovation and excellence in interventional cardiology, has been appointed Director of Pediatric Cardiology.
Dr. Josh Milner studies rare causes of common diseases such as atopic dermatitis. He uses a step by step diagnostic approach to determine if there is an underlying genetic cause.
Dr. Adolfo Ferrando and his lab members focus primarily on deciphering the mechanisms that lead to chemotherapy resistance and relapse in acute lymphoblastic leukemia.
When Dr. Wendy Chung identified the Olson children's rare disease, “It was like someone turned on the flashlight, and at least now we have a vision of how to move forward," says their mother Colleen.
Priyanka Ahimaz and other genetic counselors educate patients about genetic disorders and help them navigate the complexities of having a genetic diagnosis.
Monica Bhatia, MD, director of Columbia’s Pediatric Stem Cell Transplant Program, is participating in a trial evaluating gene editing as a curative treatment for patients with sickle cell disease.